関連する実験動画

Updated: Feb 14, 2026

Staphylococcus aureus Growth using Human Hemoglobin as an Iron Source
06:37

Staphylococcus aureus Growth using Human Hemoglobin as an Iron Source

Published on: February 7, 2013

17.2K

カテコール・キトーサン・ナノ粒子は,鉄の飢えと,Staphylococcus aureusの標的型肝臓クリアランスのための細菌の親和を可能にします

Tiannuo Wu1, Boyang Yang2, Xiaojie Yao2

  • 1School of Medicine, Guangxi University, Nanning 530004, China.

ACS applied materials & interfaces
|February 12, 2026
PubMed
まとめ

この研究は,ドキシサイクリン投与のための新しい脂質ナノ粒子を開発し,細菌標的化と肝臓保持を強化し,Staphylococcus aureus感染を効果的に治療し,有効性が向上し,バクテリア負荷が減少しました.

キーワード:
Staphylococcus aureus 黄金のスタフィロコッカス 黄金のスタフィロコッカス 黄金のスタフィロコッカスバクテリアをターゲットにしています.カテコール改変キトサンは,カテコール改変キトサンのドキシサイクリン (doxycycline) とは鉄の飢え 鉄の飢え 鉄の飢え肝臓をターゲットにしています.

さらに関連する動画

Cell Labeling and Targeting with Superparamagnetic Iron Oxide Nanoparticles08:26

Cell Labeling and Targeting with Superparamagnetic Iron Oxide Nanoparticles

Published on: October 19, 2015

12.7K
Genotyping of Staphylococcus aureus by Ribosomal Spacer PCR RS-PCR08:51

Genotyping of Staphylococcus aureus by Ribosomal Spacer PCR RS-PCR

Published on: November 4, 2016

10.2K

関連する概念動画

Hepatic Drug Clearance: Restrictive and Nonrestrictive Clearance01:09

Hepatic Drug Clearance: Restrictive and Nonrestrictive Clearance

Hepatic clearance refers to the volume of blood cleared of a drug by the liver per unit of time. It plays a crucial role in drug metabolism and elimination. While hepatic clearance is commonly estimated by subtracting renal clearance from total body clearance, other pathways, such as pulmonary or biliary clearance, may also contribute. However, these pathways are generally less significant than hepatic and renal clearance.
Most drugs undergo restrictive clearance, which is proportional to the...
550
Hepatic Drug Clearance: Role of Transporters01:14

Hepatic Drug Clearance: Role of Transporters

In the liver and bile canaliculi, influx and efflux transporters modification can influence intrinsic clearance. Transporters play a significant role in moving drugs within liver cells. Elaborate models, such as the Biopharmaceutical Classification System (BCS), are essential to relate transporters to drug disposition. This system categorizes drugs into four classes based on solubility and permeability, providing insights into elimination routes and the effects of transporters following oral...
312
Hepatic Drug Clearance: Effect of Protein Binding01:09

Hepatic Drug Clearance: Effect of Protein Binding

Hepatic clearance is influenced by protein binding based on the drug's extraction ratio. Drugs with high extraction ratios are considered flow-limited and remain unaffected by protein binding during hepatic clearance. On the other hand, drugs with low extraction ratios may be impacted by plasma protein binding, although the extent of this influence depends on the fraction of the drug bound.
For low-extraction-ratio drugs that are less than 80% protein-bound, minor changes in protein binding...
566
Affinity and Avidity01:41

Affinity and Avidity

Overview
39.3K
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance01:07

Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance

Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
304
Electron Affinity03:07

Electron Affinity

The electron affinity (EA) is the energy change for adding an electron to a gaseous atom to form an anion (negative ion).
43.7K